Kangmei Pharmaceutical Statistics

Total Valuation

SHA:600518 has a market cap or net worth of CNY 27.45 billion. The enterprise value is 27.35 billion.

Market Cap	27.45B
Enterprise Value	27.35B

Important Dates

The last earnings date was Saturday, April 19, 2025.

Earnings Date	Apr 19, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:600518 has 13.86 billion shares outstanding. The number of shares has increased by 62.20% in one year.

Current Share Class	13.86B
Shares Outstanding	13.86B
Shares Change (YoY)	+62.20%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	11.16%
Float	10.02B

Valuation Ratios

The trailing PE ratio is 2,857.00.

PE Ratio	2,857.00
Forward PE	n/a
PS Ratio	5.19
PB Ratio	2.29
P/TBV Ratio	2.32
P/FCF Ratio	98.51
P/OCF Ratio	81.62
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 68.04, with an EV/FCF ratio of 98.15.

EV / Earnings	2,846.51
EV / Sales	5.17
EV / EBITDA	68.04
EV / EBIT	n/a
EV / FCF	98.15

Financial Position

The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.01.

Current Ratio	2.74
Quick Ratio	2.58
Debt / Equity	0.01
Debt / EBITDA	0.17
Debt / FCF	0.24
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.13% and return on invested capital (ROIC) is 0.56%.

Return on Equity (ROE)	0.13%
Return on Assets (ROA)	0.35%
Return on Invested Capital (ROIC)	0.56%
Return on Capital Employed (ROCE)	0.72%
Revenue Per Employee	1.20M
Profits Per Employee	2,179
Employee Count	4,409
Asset Turnover	0.34
Inventory Turnover	2.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.00% in the last 52 weeks. The beta is 0.72, so SHA:600518's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-1.00%
50-Day Moving Average	2.07
200-Day Moving Average	2.11
Relative Strength Index (RSI)	45.16
Average Volume (20 Days)	135,892,804

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:600518 had revenue of CNY 5.29 billion and earned 9.61 million in profits. Earnings per share was 0.00.

Revenue	5.29B
Gross Profit	829.13M
Operating Income	87.36M
Pretax Income	37.67M
Net Income	9.61M
EBITDA	374.88M
EBIT	87.36M
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 167.42 million in cash and 66.62 million in debt, giving a net cash position of 100.80 million or 0.01 per share.

Cash & Cash Equivalents	167.42M
Total Debt	66.62M
Net Cash	100.80M
Net Cash Per Share	0.01
Equity (Book Value)	12.00B
Book Value Per Share	1.41
Working Capital	8.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 336.31 million and capital expenditures -57.67 million, giving a free cash flow of 278.65 million.

Operating Cash Flow	336.31M
Capital Expenditures	-57.67M
Free Cash Flow	278.65M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 15.68%, with operating and profit margins of 1.65% and 0.18%.

Gross Margin	15.68%
Operating Margin	1.65%
Pretax Margin	0.71%
Profit Margin	0.18%
EBITDA Margin	7.09%
EBIT Margin	1.65%
FCF Margin	5.27%

Dividends & Yields

SHA:600518 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.20%
Shareholder Yield	-62.20%
Earnings Yield	0.04%
FCF Yield	1.02%

Stock Splits

The last stock split was on June 16, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jun 16, 2015
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a